Diagnostics

My Quest Story – Allan Mendez

NORTHAMPTON, MA / ACCESSWIRE / March 5, 2024 / A chance encounter at a previous job put me on the…

9 months ago

LinusBio Named “Fierce 15” Company of 2023 by Fierce Medtech

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--LinusBio, a leader in precision exposome sequencing, today announced its inclusion in Fierce Medtech's "Fierce 15" list…

9 months ago

Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Company Continues to Build and Expand the Global IP Portfolio of Its One-of-a-Kind TechnologyCHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO),…

9 months ago

Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024

ANN ARBOR, MI / ACCESSWIRE / March 5, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

9 months ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans•…

9 months ago

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic

Dr. Jay Wohlgemuth, former Chief Medical & Scientific Officer of Quest Diagnostics and Dr. Ray Tabibiazar, a seasoned industry executive,…

9 months ago

First PFAS “Forever Chemicals” Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com

Directed at individuals who may be at risk of elevated PFAS exposure, the new test detects and measures PFAS identified…

9 months ago

Koneksa Appoints Dr. Jessie Bakker as Vice President of Clinical Development

NEW YORK--(BUSINESS WIRE)--#biotech--Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President…

9 months ago

Intelligent Scopes Launches Helga AI-GEP™, an AI Platform for Gastroenterology with the Commencement of Validation of its AI Software Tool for Colon Cancer

NEW YORK and LONDON, March 04, 2024 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, specializing in state-of-the-art image enhancement and precision…

9 months ago

On Rare Disease Day, Q4HE Collaboration Highlights Purpose in Action

NORTHAMPTON, MA / ACCESSWIRE / February 29, 2024 / Quest Diagnostics No-cost laboratory testing: Fourth-year dental student, Tyesha Younger MS,…

9 months ago